London based medical devices company Smith and Nephew revealed that its single use Negative Pressure Wound Therapy (NPWT) system, PICO has been approved by the US Food and Drug Administration to be used in both hospital and homecare settings.
The pocket sized device has already been approved in Canada, Europe and Australia and the FDA's approval means that NPWT will now be an option for patients undergoing orthopaedic surgery, plastic surgery and general surgical procedures.
AdvertisementStating that PICO was the perfect example of the company's commitment towards innovation, Smith & Nephew Advanced Wound Management president, Thomas Dugan said, "We are the first company to deliver effective, single use, disposable NPWT using the combination of a small, portable pump and advanced dressing technology. The PICO system demonstrates our commitment to innovation and reinforces our pledge to help reduce the human and economic cost of wounds."
P Novartis to Initiate Recall of OTC Drugs Excedrin and Bufferin New Research: in 1862 People Spent 13 Times as Much on Groceries as We Do Now M
You May Also Like